Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date | Article Title |
Journal |
|---|---|---|---|
|
Julia Wilkerson, Kald Abdallah, Charles Hugh-Jones, Greg Curt, Mace Rothenberg, Ronit Simantov, Martin Murphy, Joseph Morrell, Joel Beetsch, Daniel J. Sargent, Howard I. Scher, Peter Lebowitz,, Richard Simon, Wilfred D. Stein, Susan E. Bates, Tito Fojo |
January 2017 | Estimation of Tumour Regression and Growth Rates During Treatment in Patients with Advanced Prostate Cancer: A Retrospective Analysis | The Lancet Oncology |
|
N. Geifman, A.J Butte |
May 2016 | A Patient-Level Data Meta-Analysis of Standard-of-Care Treatments from Eight Prostate Cancer Clinical Trials | Nature Scientific Data |
|
Monica M. Bertagnolli, Oliver Sartor, Bruce A. Chabner, Mace L. Rothenberg, Sean Khozin, Charles Hugh-Jones, David M. Reese, Martin J. Murphy |
March 2017 | Sounding Board: Advantages of a Truly Open-Access Data-Sharing Model | New England Journal of Medicine |
|
Hitesh B. Mistry |
November 2017 | On the relationship between tumour growth rate and survival in non-small cell lung cancer | PeerJ |
|
Bethany Pitcher, Leila Khoja, Robert J. Hamilton, Kald Abdallah, Melania Pintilie, Anthony M. Joshua |
February 2017 | Assessment of a Prognostic Model, PSA Metrics and Toxicities in Metastatic Castrate Resistant Prostate Cancer using Data from Project Data Sphere. | PLOS ONE |
|
Paul Germonpré, Tim Van den Wyngaert and Conteporary Clinical Trials authors are: Louis Dron, Shirin Golchi, Grace Hsu, Kristian Thorlund |
April 2019 | Second-Line Erlotinib After Failure of Pemetrexed-Containing Chemotherapy in Advanced non-Small Cell Lung Cancer (NSCLC): Real-World Effectiveness, Safety and Tolerability | PLOS ONE |
|
S. Peter Wu, Moses Tam, Raymond Mailhot Vega, Carmen A. Perez, Naamit Kurshan Gerber |
November 2017 | Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up | Radiation Oncology |
|
Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan J. Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Tarek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group |
May 2018 | Myocarditis Associated with Immune Checkpoint Inhibitors: an Expert Consensus on Data Gaps and a Call to Action | The Oncologist |
|
Angela K. Green, Robert W. Corty, William A. Wood, Mathew Meeneghan, Katherine E. Reeder-Hayes, Ethan Basch, Matthew I Milowsky, Stacie B. Dusetzina |
May 2015 | Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone alone in Metastatic Castrate-resistant Prostate Cancer after Docetaxel Failure | The Oncologist |
|
Kald Abdallah, Charles Hugh-Jones, Thea Norman, Stephen Friend, Gustavo Stolovitzky |
May 2017 | The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer | The Oncologist |
|
Angela K. Green, Katherine E. Reeder-Hayes, Robert W. Corty, Ethan Basch, Mathew I. Milowsky, Stacie B. Dusetzina, Antonia V. Bennett, William A. Wood |
May 2017 | The Project Data Sphere Initiative: Accelerating Cancer Research by Sharing Data | The Oncologist |
|
Saki Nishiyama, Mamoru Narukawa |
February 2022 | Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials | The Oncologist |
|
Patrick M. Cotogno, Lahiru K. Ranasinghe, Elisa M. Ledet, Brian E. Lewis, Oliver Sartor |
April 2018 | Laboratory-Based Biomarkers and Liver Metastases in Metastatic Castration-Resistant Prostate Cancer | The Oncologist |
|
Fadi S. Dahdaleh, Scott K. Sherman, Elizabeth C. Poli, Janani Vigneswaran, Blase N. Polite, Manish R. Sharma, Daniel V. Catenacci, Steven B. Maron, Kiran K. Turaga |
October 2018 | Obstruction Predicts Worse Long-term Outcomes in Stage III Colon Cancer: A Secondary Analysis of the N0147 Trial | Surgery |
